Factor XIII (Human) and Lenvatinib Mesylate
Determining the interaction of Factor XIII (Human) and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: factor XIII
Brand name: Corifact, Tretten
Synonyms: Factor XIII, Factor XIII A-Subunit (Recombinant)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor XIII (Human)-Lenvima
- Factor XIII (Human)-Lenvima (14 MG Daily Dose)
- Factor XIII (Human)-Lenvima (18 MG Daily Dose)
- Factor XIII (Human)-Lenvima (20 MG Daily Dose)
- Factor XIII (Human)-Lenvima (24 MG Daily Dose)
- Factor XIII (Human)-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Factor XIII A-Subunit (Recombinant)
- Lenvatinib Mesylate-Factor XIII Concentrate (Human)
- Lenvatinib Mesylate-Factor xiii Intravenous
- Lenvatinib Mesylate-Factrel
- Lenvatinib Mesylate-FaLessa
- Lenvatinib Mesylate-FaLessa Kit